BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2297354)

  • 1. Mechanism of the synergistic antiviral and cytostatic activity of (RS)-3-(adenin-9-yl)-2-hydroxypropanoic acid isobutyl ester and D,L-homocysteine.
    Cools M; Hasobe M; De Clercq E; Borchardt RT
    Biochem Pharmacol; 1990 Jan; 39(1):195-202. PubMed ID: 2297354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2-Methylpropyl ester of 3-(adenin-9-yl)-2-hydroxypropanoic acid. Mechanism of antiviral action in vaccinia virus-infected L929 cells.
    Votruba I; Hasobe M; Holý A; Borchardt RT
    Biochem Pharmacol; 1990 May; 39(10):1573-80. PubMed ID: 2337414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of S-adenosylhomocysteine hydrolase inhibitors on S-adenosylhomocysteine and S-adenosylmethionine pool levels in L929 cells.
    Cools M; De Clercq E
    Biochem Pharmacol; 1990 Nov; 40(10):2259-64. PubMed ID: 2244927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elucidation of the mechanism by which homocysteine potentiates the anti-vaccinia virus effects of the S-adenosylhomocysteine hydrolase inhibitor 9-(trans-2',trans-3'-dihydroxycyclopent-4'-enyl)-adenine.
    Hasobe M; McKee JG; Ishii H; Cools M; Borchardt RT; De Clercq E
    Mol Pharmacol; 1989 Sep; 36(3):490-6. PubMed ID: 2779528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between the antiviral activity of acyclic and carbocyclic adenosine analogues in murine L929 cells and their inhibitory effect on L929 cells S-adenosylhomocysteine hydrolase.
    Cools M; de Clercq E
    Biochem Pharmacol; 1989 Apr; 38(7):1061-7. PubMed ID: 2539815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Homocysteine potentiates the antiviral and cytostatic activity of those nucleoside analogues that are targeted at S-adenosylhomocysteine hydrolase.
    De Clercq E; Cools M; Balzarini J
    Biochem Pharmacol; 1989 Jun; 38(11):1771-8. PubMed ID: 2735935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of antiviral and cytotoxic action of (+/-)-6' beta-fluoroaristeromycin, a potent inhibitor of S-adenosylhomocysteine hydrolase.
    Cools M; Balzarini J; De Clercq E
    Mol Pharmacol; 1991 Jun; 39(6):718-24. PubMed ID: 2051990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiviral activity of S-adenosylhomocysteine hydrolase inhibitors against plant viruses.
    De Fazio G; Alba AP; Vicente M; De Clercq E
    Antiviral Res; 1990 May; 13(5):219-26. PubMed ID: 2396830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiviral potency of adenosine analogues: correlation with inhibition of S-adenosylhomocysteine hydrolase.
    De Clercq E; Cools M
    Biochem Biophys Res Commun; 1985 May; 129(1):306-11. PubMed ID: 2988550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased transmethylation of biogenic amines after in vivo elevation of brain S-adenosyl-l-homocysteine.
    Schatz RA; Wilens TE; Sellinger OZ
    J Neurochem; 1981 May; 36(5):1739-48. PubMed ID: 7241133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of 4'-modified analogs of aristeromycin on the metabolism of S-adenosyl-L-homocysteine in murine L929 cells.
    Ault-Riché DB; Lee Y; Yuan CS; Hasobe M; Wolfe MS; Borcherding DR; Borchardt RT
    Mol Pharmacol; 1993 Jun; 43(6):989-97. PubMed ID: 8316227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of 9-(trans-2',trans-3'-dihydroxycyclopent-4'-enyl)-adenine and -3-deazaadenine on the metabolism of S-adenosylhomocysteine in mouse L929 cells.
    Hasobe M; Mckee JG; Borcherding DR; Keller BT; Borchardt RT
    Mol Pharmacol; 1988 Jun; 33(6):713-20. PubMed ID: 2454388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between intracellular concentration of S-adenosylhomocysteine and inhibition of vaccinia virus replication and inhibition of murine L-929 cell growth.
    Hasobe M; McKee JG; Borchardt RT
    Antimicrob Agents Chemother; 1989 Jun; 33(6):828-34. PubMed ID: 2764532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disposition of homocysteine and S-3-deazaadenosylhomocysteine in cells exposed to 3-deazaadenosine.
    Svardal A; Djurhuus R; Ueland PM
    Mol Pharmacol; 1986 Aug; 30(2):154-8. PubMed ID: 3736540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiretroviral activity of mechanism-based irreversible inhibitors of S-adenosylhomocysteine hydrolase.
    Prakash NJ; Davis GF; Jarvi ET; Edwards ML; McCarthy JR; Bowlin TL
    Life Sci; 1992; 50(19):1425-35. PubMed ID: 1374145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of erythrocyte accumulation of methylation inhibitor S-adenosylhomocysteine in uremia.
    Perna AF; Ingrosso D; De Santo NG; Galletti P; Zappia V
    Kidney Int; 1995 Jan; 47(1):247-53. PubMed ID: 7731153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of aliphatic adenine analogues on S-adenosylhomocysteine and S-adenosylhomocysteine hydrolase in intact rat hepatocytes.
    Schanche JS; Schanche T; Ueland PM; Holý A; Votruba I
    Mol Pharmacol; 1984 Nov; 26(3):553-8. PubMed ID: 6493210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inactivation of S-adenosylhomocysteine hydrolase by 9-beta-D-arabinofuranosyladenine in intact cells.
    Helland S; Ueland PM
    Cancer Res; 1982 Mar; 42(3):1130-6. PubMed ID: 7059972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disposition of homocysteine in rat hepatocytes and in nontransformed and malignant mouse embryo fibroblasts following exposure to inhibitors of S-adenosylhomocysteine catabolism.
    Svardal AM; Djurhuus R; Refsum H; Ueland PM
    Cancer Res; 1986 Oct; 46(10):5095-100. PubMed ID: 3756867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of transmethylation disturbs neurulation in chick embryos.
    Afman LA; Blom HJ; Drittij MJ; Brouns MR; van Straaten HW
    Brain Res Dev Brain Res; 2005 Aug; 158(1-2):59-65. PubMed ID: 15996755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.